| 01/12/23 | 07:00:07 | 1 Dec 2023 | | Exercise of Share Options and Total Voting Rights | RNS |
| 29/11/23 | 12:40:01 | 29 Nov 2023 | | Exercise of Share Options and Total Voting Rights | RNS |
| 07/11/23 | 11:00:00 | 7 Nov 2023 | | Exercise of Share Options and Total Voting Rights | RNS |
| 16/10/23 | 07:00:14 | 16 Oct 2023 | | Audited Preliminary Results | RNS |
| 12/10/23 | 07:00:14 | 12 Oct 2023 | | Additional Investor Presentation | RNS |
| 10/10/23 | 16:45:00 | 10 Oct 2023 | | Exercise of Share Options and Total Voting Rights | RNS |
| 02/10/23 | 11:50:01 | 2 Oct 2023 | | Holding(s) in Company | RNS |
| 28/09/23 | 14:00:00 | 28 Sept 2023 | | Exercise of Share Options and Total Voting Rights | RNS |
| 26/09/23 | 14:40:01 | 26 Sept 2023 | | Holding(s) in Company | RNS |
| 25/09/23 | 08:40:01 | 25 Sept 2023 | | Holding(s) in Company | RNS |
| 22/09/23 | 15:40:01 | 22 Sept 2023 | | Holding(s) in Company | RNS |
| 12/09/23 | 07:00:06 | 12 Sept 2023 | | Notice of Results | RNS |
| 04/09/23 | 07:00:05 | 4 Sept 2023 | | Health Canada regulatory approval submission | RNS |
| 31/07/23 | 08:05:01 | 31 Jul 2023 | | Holding(s) in Company | RNS |
| 28/07/23 | 08:28:46 | 28 Jul 2023 | | Director/PDMR Shareholding | RNS |
| 25/07/23 | 07:00:05 | 25 Jul 2023 | | Trading update | RNS |
| 12/07/23 | 07:00:02 | 12 Jul 2023 | | Shareholder Open Day and Notice of Trading Update | RNS |
| 10/07/23 | 07:00:02 | 10 Jul 2023 | | Exercise of Share Options and Total Voting Rights | RNS |
| 26/06/23 | 07:00:04 | 26 Jun 2023 | | Director/PDMR Shareholding | RNS |
| 22/06/23 | 16:01:04 | 22 Jun 2023 | | Holding(s) in Company | RNS |
| 16/06/23 | 07:00:04 | 16 Jun 2023 | | Exercise of Share Options and Total Voting Rights | RNS |
| 14/06/23 | 16:10:01 | 14 Jun 2023 | | Holding(s) in Company | RNS |
| 06/06/23 | 17:00:01 | 6 Jun 2023 | | Exercise of Share Options and Total Voting Rights | RNS |
| 05/06/23 | 10:00:01 | 5 Jun 2023 | | Analyst and Investor presentation | RNS |
| 05/06/23 | 07:00:06 | 5 Jun 2023 | | FDA De Novo approval | RNS |
| 28/03/23 | 11:30:01 | 28 Mar 2023 | | Issue of Equity | RNS |
| 27/03/23 | 07:00:04 | 27 Mar 2023 | | Successful submission of additional data to US FDA | RNS |
| 14/03/23 | 14:05:29 | 14 Mar 2023 | | Second Price Monitoring Extn | RNS |
| 14/03/23 | 14:00:15 | 14 Mar 2023 | | Price Monitoring Extension | RNS |
| 14/03/23 | 09:30:01 | 14 Mar 2023 | | Issue of Equity | RNS |
| 22/02/23 | 16:30:01 | 22 Feb 2023 | | Issue of Equity | RNS |
| 20/02/23 | 07:00:03 | 20 Feb 2023 | | Half-year Report | RNS |
| 30/01/23 | 07:00:04 | 30 Jan 2023 | | Notice of Results and Investor presentation | RNS |
| 14/12/22 | 11:00:44 | 14 Dec 2022 | | Result of AGM - Replacement | RNS |
| 13/12/22 | 07:00:02 | 13 Dec 2022 | | Issue of Equity | RNS |
| 12/12/22 | 11:26:03 | 12 Dec 2022 | | Result of AGM | RNS |
| 12/12/22 | 07:00:02 | 12 Dec 2022 | | AGM Statement | RNS |
| 02/11/22 | 13:50:01 | 2 Nov 2022 | | Holding(s) in Company | RNS |
| 25/10/22 | 07:00:06 | 25 Oct 2022 | | Audited Preliminary Results | RNS |
| 06/10/22 | 09:15:01 | 6 Oct 2022 | | Issue of Equity | RNS |
| 04/10/22 | 12:00:00 | 4 Oct 2022 | | Appointment of new Company Secretary | RNS |
| 04/10/22 | 07:00:06 | 4 Oct 2022 | | Notice of Results & Investor Presentation | RNS |
| 29/09/22 | 13:00:07 | 29 Sept 2022 | | North America update | RNS |
| 30/08/22 | 07:00:15 | 30 Aug 2022 | | Holding(s) in Company | RNS |
| 22/07/22 | 13:05:04 | 22 Jul 2022 | | Director/PDMR Shareholding | RNS |
| 21/07/22 | 10:15:00 | 21 Jul 2022 | | Holding(s) in Company | RNS |
| 18/07/22 | 16:41:14 | 18 Jul 2022 | | Second Price Monitoring Extn | RNS |
| 18/07/22 | 16:35:50 | 18 Jul 2022 | | Price Monitoring Extension | RNS |
| 18/07/22 | 07:00:05 | 18 Jul 2022 | | Trading update and special dividend | RNS |
| 30/06/22 | 07:00:04 | 30 Jun 2022 | | De Novo FDA submission for Tristel Duo ULT | RNS |
